enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Autosomal dominant polycystic kidney disease - Wikipedia

    en.wikipedia.org/wiki/Autosomal_dominant...

    [1] [24] Studies led by Mayo Clinic professionals established that the total kidney volume (TKV) in a large cohort of ADPKD patients was 1060 ± 642ml with a mean increase of 204ml over three years, or 5.27% per year in the natural course of the disease, among other important, novel findings that were extensively studied for the first time.

  3. Lixivaptan - Wikipedia

    en.wikipedia.org/wiki/Lixivaptan

    As of December 2021, lixivaptan is in Phase III clinical development for the treatment of Autosomal dominant polycystic kidney disease (ADPKD), the most common form of polycystic kidney disease. The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to lixivaptan for the treatment of ADPKD.

  4. Polycystic kidney disease 3 (autosomal dominant) - Wikipedia

    en.wikipedia.org/wiki/Polycystic_kidney_disease...

    n/a Ensembl n/a n/a UniProt n a n/a RefSeq (mRNA) n/a n/a RefSeq (protein) n/a n/a Location (UCSC) n/a n/a PubMed search n/a Wikidata View/Edit Human Polycystic kidney disease 3 (autosomal dominant) is a protein that in humans is encoded by the PKD3 gene. Polycystic kidney disease (ADPKD) is a life threatening hereditary disorder; it is characterized by the development of fluid-filled cyst ...

  5. Polycystic kidney disease - Wikipedia

    en.wikipedia.org/wiki/Polycystic_kidney_disease

    Autosomal dominant polycystic kidney disease (ADPKD) is the most common of all the inherited cystic kidney diseases [12] [13] [14] with an incidence of 1:500 live births. [ 12 ] [ 14 ] Studies show that 10% of end-stage kidney disease (ESKD) patients being treated with dialysis in Europe and the U.S. were initially diagnosed and treated for ADPKD.

  6. Nephrogenic diabetes insipidus - Wikipedia

    en.wikipedia.org/wiki/Nephrogenic_diabetes_insipidus

    Nephrogenic diabetes insipidus is most common in its acquired forms, meaning that the defect was not present at birth. These acquired forms have numerous potential causes. The most obvious cause is a kidney or systemic disorder, including amyloidosis, [2] polycystic kidney disease, [3] electrolyte imbalance, [4] [5] or some other kidney defect. [2]

  7. Autosomal recessive polycystic kidney disease - Wikipedia

    en.wikipedia.org/wiki/Autosomal_recessive...

    Autosomal recessive polycystic kidney disease (ARPKD) is the recessive form of polycystic kidney disease. It is associated with a group of congenital fibrocystic syndromes. [ 5 ] Mutations in the PKHD1 (chromosomal locus 6p12.2) cause ARPKD.

  8. VISTA (comparative genomics) - Wikipedia

    en.wikipedia.org/wiki/VISTA_(comparative_genomics)

    The VISTA family of tools is developed and hosted at the Genomics Division of Lawrence Berkeley National Laboratory.This collaborative effort is supported by the Programs for Genomic Applications grant from the NHLBI/NIH and the Office of Biological and Environmental Research, Office of Science, US Department of Energy.

  9. National Institute of Diabetes and Digestive and Kidney ...

    en.wikipedia.org/wiki/National_Institute_of...

    The mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is to conduct and support medical research and research training and to disseminate science-based information on diabetes and other endocrine and metabolic diseases; digestive diseases, nutritional disorders, and obesity; and kidney, urological, and hematologic diseases, to improve people's health and ...